DAM
PRAX icon

DLD Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

DLD Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,400
Closed -$3.06M – 433
2025
Q4 		$3.06M Buy
+10,400
New +$1.94M 0.23% 71

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

DLD Asset Management's PRAX Position: Q1 2024 in Review

DLD Asset Management sold out of Praxis Precision Medicines (PRAX) in Q1 2024, closing a stake of 10,000 shares — an estimated $223K sold.

DLD Asset Management first reported a position in PRAX in Q4 2023 and held it in 1 quarter. The position peaked at $223K in Q4 2023. 111 funds tracked by Wall St. Rank hold PRAX as of Q1 2024.

  • DLD Asset Management reported no remaining Praxis Precision Medicines position as of Q1 2024 after selling out during the quarter.
  • DLD Asset Management sold 10,000 Praxis Precision Medicines shares in Q1 2024, an estimated $223K.
  • DLD Asset Management first reported a position in Praxis Precision Medicines in Q4 2023 and held it in 1 quarter.
  • DLD Asset Management's Praxis Precision Medicines position peaked at $223K in Q4 2023.
  • 111 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2024.

Based on DLD Asset Management's 13F filing for Q1 2024, filed 14 May 2024.